Arcutis Biotherapeutics, Inc.

SEC 4 · Filed

0001628280-26-014639Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 2, 2026

Sale by Welgus Howard G.

Security
Common Stock
Code
S
Shares
10,000
Price per share
25.65Reported 25.6518
Structured facts
{
  "code": "S",
  "date": "2026-03-02",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026.",
    "F2": "The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.37 to $26.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001801050",
      "name": "Welgus Howard G.",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "49744",
  "price": "25.6518",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "10000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}